Retraction:

Dantong Cheng^1,*, Senlin Zhao^1,5,*, Huamei Tang^2,*, Dongyuan Zhang¹, Hongcheng Sun¹, Fudong Yu¹, Weiliang Jiang^4,*, Ben Yue¹, Jingtao Wang¹, Meng Zhang³, Yang Yu¹, Xisheng Liu¹, Xiaofeng Sun⁵, Zongguang Zhou⁶, Xuebin Qin⁷, Xin Zhang⁸, Dongwang Yan¹, Yugang Wen^1,5 and Zhihai Peng¹

¹Department of General Surgery, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
²Department of Pathology, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
³Department of Pathology, Fudan University Affiliated Shanghai Cancer Center, Shanghai, China
⁴Department of Gastroenterology, Shanghai General Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China
⁵Department of Oncology and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden
⁶Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China
⁷Department of Neuroscience, School of Medicine, Temple University, Philadelphia, PA, USA
⁸Department of Pathology, Zhejiang Provincial People’s Hospital, Hangzhou, Zhejiang, China
^*These authors contributed equally to this work

Published: November 07, 2024

Copyright: © 2024 Cheng et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been retracted: In Figure 5D, the same western blot image was used for both the HT29 and HCT116 cell groups. The authors are unable to make corrections using the original data. As a result, the Editorial decision was made to retract this paper. All authors agreed with the decision. The Shanghai Jiao Tong University authorities were notified about the issues in this paper.

Original article: Oncotarget. 2016; 7:45199–45213. DOI: https://doi.org/10.18632/oncotarget.9900.